Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 17 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Pirtobrutinib for chronic lymphocytic leukaemia or small lymphocytic lymphoma after BTK inhibitor therapy	Pirtobrutinib (LY3527727; LOXO-305)	Chronic lymphocytic leukaemia (CLL) , Small lymphocytic lymphoma (SLL)	Haematological Cancer and Lymphomas	2023	View \| Download
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma	Pirtobrutinib (LY3527727; LOXO-305)	Chronic lymphocytic leukaemia (CLL) , Small lymphocytic lymphoma (SLL)	Haematological Cancer and Lymphomas	2023	View \| Download
Ublituximab (TG-1101) in combination with umbralisib (TGR-1202) for chronic lymphocytic leukaemia	Ublituximab (TG-1101; LFB-R603) , Umbralisib (TGR-1202; RP-5264)	Chronic lymphocytic leukaemia (CLL)	Haematological Cancer and Lymphomas	2017	View \| Download
Ublituximab in Combination with Ibrutinib for High Risk Chronic Lymphocytic Leukaemia	Ibrutinib (Imbruvica) , Ublituximab (TG-1101; LFB-R603)	Chronic lymphocytic leukaemia (CLL)	Haematological Cancer and Lymphomas	2018	View \| Download
Venetoclax in Combination with Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukaemia – First Line	Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199)	Chronic lymphocytic leukaemia (CLL)	Haematological Cancer and Lymphomas	2017	View \| Download
Zanubrutinib for previously untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma	Zanubrutinib (BGB-3111; Brukinsa)	Chronic lymphocytic leukaemia (CLL) , Small lymphocytic lymphoma (SLL)	Haematological Cancer and Lymphomas	2022	View \| Download
Zanubrutinib for relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma	Zanubrutinib (BGB-3111; Brukinsa)	Chronic lymphocytic leukaemia (CLL) , Small lymphocytic lymphoma (SLL)	Haematological Cancer and Lymphomas	2022	View \| Download